Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy...
Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popular...
Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical developme...
Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first ...
Mumbai: Piramal Healthcare, an innovation led company, has agreed to acquire Decision Resources Group (DRG) a US-based c...
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...
New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine...
Hyderabad: Dr. Reddy's Laboratories launched Zenatane (isotretinoin) capsules in 20 mg and 40 mg in the US. The drug i...
New Delhi: Transasia BioMedicals, one of India's largest IVD companies, was recently conferred with the coveted 'Niryat ...
Singapore: The Foreign Investment Promotion Board (FIPB) in India cleared six investment proposals in the pharmaceutical...
Hyderabad: Dr. Reddy's Laboratories has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio...
Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-relea...
Singapore: Sri Lanka's Ministry of Health has decided to ban the purchase of drugs from four Indian pharmaceutical compa...
Singapore: If reports are to be believed, vegetarian and non-vegetarian capsules will soon hit the Indian market, offeri...
Singapore: Indian Council of Scientific and Industrial Research (CSIR) through its constituent laboratories has conduct...
New Delhi: The McKinsey report, commissioned by the US-India Chamber of Commerce, was released at the recently held US-I...
Singapore: Frost & Sullivan (F&S) has awarded Boehringer Ingelheim (BI) the 'Pharmaceutical Brand of the Year - ...
Drug pricing pressures, stricter regulatory environments and the economic downturn are all pushing the global pharmaceut...
